cellular
• a 35% increase in death-associated protein kinase (DAPK) activity in primary MEFs derived from mutant mice
• mutant mice are normal with no obvious neurological, gross, or developmental alterations
|
• in tunicamycin-treated MEFs and in C6-ceramide-induced cell death in hippocampal neurons
|
homeostasis/metabolism
• NMDA-induced brain lesions are significantly greater mutant mice
• after MCAO treatment, infarct volume is significantly greater in mutant mice
|
nervous system
• NMDA-induced brain lesions are significantly greater mutant mice
• after MCAO treatment, infarct volume is significantly greater in mutant mice
|